Cell Reports (Mar 2017)

A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2

  • Jing Zhou,
  • An-Chi Tien,
  • John A. Alberta,
  • Scott B. Ficarro,
  • Amelie Griveau,
  • Yu Sun,
  • Janhavee S. Deshpande,
  • Joseph D. Card,
  • Meghan Morgan-Smith,
  • Wojciech Michowski,
  • Rintaro Hashizume,
  • C. David James,
  • Keith L. Ligon,
  • William D. Snider,
  • Peter Sicinski,
  • Jarrod A. Marto,
  • David H. Rowitch,
  • Charles D. Stiles

DOI
https://doi.org/10.1016/j.celrep.2017.03.003
Journal volume & issue
Vol. 18, no. 13
pp. 3167 – 3177

Abstract

Read online

During development of the vertebrate CNS, the basic helix-loop-helix (bHLH) transcription factor Olig2 sustains replication competence of progenitor cells that give rise to neurons and oligodendrocytes. A pathological counterpart of this developmental function is seen in human glioma, wherein Olig2 is required for maintenance of stem-like cells that drive tumor growth. The mitogenic/gliomagenic functions of Olig2 are regulated by phosphorylation of a triple serine motif (S10, S13, and S14) in the amino terminus. Here, we identify a set of three serine/threonine protein kinases (glycogen synthase kinase 3α/β [GSK3α/β], casein kinase 2 [CK2], and cyclin-dependent kinases 1/2 [CDK1/2]) that are, collectively, both necessary and sufficient to phosphorylate the triple serine motif. We show that phosphorylation of the motif itself serves as a template to prime phosphorylation of additional serines and creates a highly charged “acid blob” in the amino terminus of Olig2. Finally, we show that small molecule inhibitors of this forward-feeding phosphorylation cascade have potential as glioma therapeutics.

Keywords